Page 1 of Clinical Trials for Gilead Sciences [SPONSOR-COLLABORATORS], 302 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Terminated
(ARTEMIS-IPF)Randomized, Placebo-Controlled Study to Evaluate Safety and Effectiveness of Ambrisentan in IPF
Last Updated: December 24, 2010
Condition(s): Idiopathic Pulmonary Fibrosis
2
Active, not recruiting
Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B
Last Updated: April 7, 2008
Condition(s): Chronic Hepatitis B
3
Completed
Safety Study of Tecadenoson to Treat Atrial Fibrillation
Last Updated: March 23, 2011
Condition(s): Atrial Fibrillation
4
Recruiting
Study to Evaluate the Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) in Combination With Peginterferon α-2a vs Standard of Care Tenofovir Disoproxil Fumarate Monotherapy or Peginterferon α-2a Monotherapy for 48 Weeks in Chronic Hepatitis B(CHB).
Last Updated: May 18, 2012
Condition(s): Chronic Hepatitis B
5
Completed
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Assess Safety and Efficacy of Ambrisentan in Subjects With Pulmonary Arterial Hypertension.
Last Updated: April 15, 2009
Condition(s): Pulmonary Arterial Hypertension
6
Completed
ROCKET II - Randomized Open Label Switch for Cholesterol Elevation on Kivexa + Kaletra Evaluation Trial
Last Updated: November 18, 2011
Condition(s): HIV-1
7
Recruiting
Phase 3b Open Label Study to Evaluate Switching From Regimens Consisting of a Non-nucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV 1 Infected Patients
Last Updated: March 23, 2012
Condition(s): Acquired Immunodeficiency Syndrome; HIV Infections
8
Completed
Evaluation of the Safety, Tolerability, Pharmacokinetics, and Activity of GS-9450 in Subjects With Chronic HCV
Last Updated: May 16, 2012
Condition(s): HCV Infection
9
Not yet recruiting
A Study on the Effects of Ranolazine on Exercise Duration in Subjects With Chronic Stable Angina and Coronary Artery Disease (CAD) With Type 2 Diabetes Mellitus (T2DM)
Last Updated: April 12, 2011
Condition(s): Angina Pectoris; Coronary Artery Disease; Type 2 Diabetes Mellitus
10
Terminated
Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.
Last Updated: March 7, 2007
Condition(s): Hepatitis B
11
Active, not recruiting
A Study to Compare Tenofovir Versus Hepsera (Adefovir) for the Treatment of Hepatitis Be Antigen (HBeAg) Positive Chronic Hepatitis B
Last Updated: October 31, 2011
Condition(s): Chronic Hepatitis B
12
Completed
Study of Ambrisentan and Phosphodiesterase Type-5 Inhibitor (PDE-5i) to Treat Pulmonary Arterial Hypertension
Last Updated: March 20, 2012
Condition(s): Pulmonary Arterial Hypertension
13
Recruiting
Phase 2 Safety and Efficacy Study of CAL-101 (GS-1101) in Relapsed or Refractory Hodgkin Lymphoma
Last Updated: April 24, 2012
Condition(s): Hodgkin Lymphoma
14
Active, not recruiting
A Study to Compare Tenofovir Versus the Combination of Tenofovir Plus Emtricitabine for the Treatment of Chronic Hepatitis B in Patients With Normal ALT
Last Updated: January 5, 2011
Condition(s): Chronic Hepatitis B
15
Active, not recruiting
Study of Cicletanine for Pulmonary Arterial Hypertension (PAH)
Last Updated: August 12, 2011
Condition(s): Pulmonary Arterial Hypertension
16
Available
Expanded Access Program for Aztreonam Lysine for Inhalation in Canadian Patients With Cystic Fibrosis
Last Updated: April 4, 2012
Condition(s): Cystic Fibrosis; Pseudomonas Aeruginosa
17
Recruiting
Pilot Study of GS-6624 in the Treatment of Liver Fibrosis
Last Updated: May 2, 2012
Condition(s): Liver Fibrosis
18
Completed
ROCKET I - Randomized Open Label Switch for Cholesterol Elevation on Kivexa Evaluation Trial
Last Updated: July 30, 2010
Condition(s): HIV Infections
19
Completed
Safety, Tolerability, Pharmacokinetics and Activity of GS-9450 in Adults With Non-Alcoholic Steatohepatitis (NASH)
Last Updated: August 20, 2010
Condition(s): Nonalcoholic Steatohepatitis
20
Active, not recruiting
Phase 3, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of GS-9350-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naïve Adults
Last Updated: October 12, 2011
Condition(s): HIV; HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?spons=Gilead+Sciences

Page 1 of Clinical Trials for Gilead Sciences [SPONSOR-COLLABORATORS], 302 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About